Raymond James Financial Services Advisors, Inc. - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 130 filers reported holding OCULAR THERAPEUTIX INC in Q3 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.9%.

Quarter-by-quarter ownership
Raymond James Financial Services Advisors, Inc. ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q2 2024$497,617
+0.9%
72,751
+34.3%
0.00%0.0%
Q1 2024$493,074
+78.2%
54,184
-12.7%
0.00%
Q4 2023$276,698
+18.4%
62,040
-16.6%
0.00%
Q3 2023$233,619
-10.8%
74,401
+46.6%
0.00%
Q2 2023$261,942
+236.9%
50,764
+244.0%
0.00%
Q1 2023$77,759
+112.0%
14,755
+13.0%
0.00%
Q4 2022$36,685
-74.7%
13,055
-62.6%
0.00%
Q3 2022$145,000
+16.9%
34,873
+13.1%
0.00%
Q2 2022$124,000
+15.9%
30,828
+42.8%
0.00%
Q1 2022$107,000
-77.2%
21,584
-75.4%
0.00%
-100.0%
Q4 2021$470,000
+98.3%
87,602
+269.2%
0.00%
Q3 2021$237,000
-34.7%
23,729
-7.3%
0.00%
-100.0%
Q2 2021$363,000
-15.0%
25,593
-1.6%
0.00%0.0%
Q1 2021$427,000
-17.1%
25,999
+4.5%
0.00%0.0%
Q4 2020$515,000
+221.9%
24,890
+18.4%
0.00%
Q3 2020$160,000
-61.3%
21,014
-57.6%
0.00%
-100.0%
Q2 2020$413,000
+436.4%
49,619
+220.6%
0.00%
Q1 2020$77,00015,4760.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q3 2022
NameSharesValueWeighting ↓
SUMMER ROAD LLC 3,784,850$15,064,00062.56%
Versant Venture Management, LLC 2,215,384$8,817,228,0004.36%
SV Health Investors, LLC 628,236$2,500,0001.54%
DELTEC ASSET MANAGEMENT LLC 724,747$2,885,0000.80%
Endurant Capital Management LP 232,727$926,0000.49%
NOTTINGHAM ADVISORS, INC. 146,946$1,011,0000.15%
JGP Global Gestao de Recursos Ltda. 12,568$50,0000.06%
Man Group plc 1,187,508$4,726,0000.02%
Dynamic Technology Lab Private Ltd 21,077$84,0000.02%
NewEdge Advisors, LLC 36,250$144,0000.01%
View complete list of OCULAR THERAPEUTIX INC shareholders